- Insulin pumps and consumables – funded access widened to include cystic-fibrosis related diabetes
The CareSens brand of blood glucose meters and test strips became the sole subsidised brand from 1 March 2013. The sole supply contract for the CareSens brand ended on 30 June 2015. In light of this, PHARMAC began public consultation on the future funding approach to blood glucose meters and test strips, in March 2015. PHARMAC received 313 individual responses to the consultation from consumers, consumer groups, health professionals and suppliers of blood glucose meters and test strips. These provided input into PHARMAC’s thinking around the future funding of blood glucose meters.
Following this consultation, PHARMAC began its procurement process by seeking Expressions of Interest (EOI) from suppliers of meters and test strips. This enables suppliers to let PHARMAC know they are interested in having their products funded in the future.
With the closure of the EOI, laboratory testing and initial end-user testing will follow as part of PHARMAC’s first stage evaluation of the diabetes management products.
Until any decisions are made, the CareSens brand of meters and test strips will continue to be funded.
Last updated: 10 December 2015